Will Donald Trump Nominate Marijuana Legalizer to Head the FDA?
Marijuana legalization supporters, and other civil rights advocates, have been understandably glued to the attorney general confirmation hearings for Alabama Senator Jeff Sessions, but the upcoming nomination to head the Food and Drug Administration (FDA) could soon take center stage. The FDA has been unwilling to consider marijuana itself medicine, even though it has approved the use of three marijuana-based medicines. Marijuana law reform activists are encouraged by the possibility of Jim O’Neill being tapped to lead the FDA, as attn.com reported:
“Seeing Jim’s name floated gives us reason for a little optimism in the midst of so many old school drug warriors being tapped for other key posts,” Marijuana Majority founder Tom Angell told ATTN:. “I feel confident that if he becomes the next FDA commissioner, we will be in very good position to finally reschedule marijuana.”
Mike Liszewski, the director of government affairs at Americans for Safe Access, agreed.
...
This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.
Follow us on Instagram
Connect with us on Linkedin